UBS Group
DOCS icon

UBS Group’s Doximity DOCS Stock Holding History

UBS Group’s Portfolio DOCS Stock Details DOCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.2M Sell
654,262
-25,998
-4% -$810K ﹤0.01% 2882
2025
Q4 		$30.1M Buy
680,260
+142,408
+26% +$7.99M ﹤0.01% 2169
2025
Q3 		$39.3M Sell
537,852
-309,635
-37% -$20.2M 0.01% 1870
2025
Q2 		$52M Sell
847,487
-239,940
-22% -$13.4M 0.01% 1494
2025
Q1 		$63.1M Buy
1,087,427
+492,680
+83% +$31.1M 0.01% 1275
2024
Q4 		$31.8M Buy
594,747
+487,324
+454% +$23.9M 0.01% 1872
2024
Q3 		$4.68M Sell
107,423
-11,516
-10% -$384K ﹤0.01% 3138
2024
Q2 		$3.33M Buy
118,939
+46,512
+64% +$1.23M ﹤0.01% 3243
2024
Q1 		$1.95M Buy
72,427
+16,386
+29% +$467K ﹤0.01% 3987
2023
Q4 		$1.57M Sell
56,041
-51,187
-48% -$1.21M ﹤0.01% 4062
2023
Q3 		$2.28M Buy
107,228
+48,568
+83% +$1.33M ﹤0.01% 3318
2023
Q2 		$2M Buy
58,660
+131
+0.2% +$4.36K ﹤0.01% 3526
2023
Q1 		$1.9M Sell
58,529
-13,737
-19% -$456K ﹤0.01% 3490
2022
Q4 		$2.43M Buy
72,266
+51,550
+249% +$1.57M ﹤0.01% 3203
2022
Q3 		$626K Sell
20,716
-9,291
-31% -$340K ﹤0.01% 4148
2022
Q2 		$1.04M Sell
30,007
-57,565
-66% -$2.27M ﹤0.01% 3703
2022
Q1 		$4.56M Buy
87,572
+46,364
+113% +$2.33M ﹤0.01% 2620
2021
Q4 		$2.07M Buy
41,208
+16,532
+67% +$1.08M ﹤0.01% 3708
2021
Q3 		$1.99M Buy
24,676
+24,476
+12,238% +$1.79M ﹤0.01% 3578
2021
Q2 		$12K Buy
+200
New +$11.2K ﹤0.01% 7874

Other funds holding DOCS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group's DOCS Position: Q1 2026 in Review

UBS Group reduced its Doximity (DOCS) stake by 3.8% in Q1 2026, selling an estimated $810K and leaving 654,262 shares worth $15.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2882.

UBS Group first reported a position in DOCS in Q2 2021 and has held it in 20 quarters since. The position peaked at $63.1M in Q1 2025. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • UBS Group held 654,262 shares of Doximity worth $15.2M as of Q1 2026.
  • UBS Group sold 25,998 Doximity shares in Q1 2026, an estimated $810K.
  • Doximity made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2882 holding.
  • UBS Group first reported a position in Doximity in Q2 2021 and has held it in 20 quarters since.
  • UBS Group's Doximity position peaked at $63.1M in Q1 2025.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.